Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)
0.0260
0.00 (0.00%)
At close: Nov 18, 2026
SGXC:9G2 Revenue
Singapore Institute of Advanced Medicine Holdings had revenue of 4.63M SGD in the quarter ending September 30, 2026, with 11.98% growth. This brings the company's total for the last twelve months to 16.11M, up 1.85% year-over-year. In the fiscal year ending June 30, 2026, Singapore Institute of Advanced Medicine Holdings had annual revenue of 15.72M with 0.05% growth. That makes Singapore Institute of Advanced Medicine Holdings the 36,354th largest company in the world by revenue and 436th in Singapore.
Revenue (ttm)
16.11M
Revenue Growth
+1.85%
P/S Ratio
2.78
Revenue / Employee
154.90K
Employees
104
Market Cap
44.83M
Revenue by Segment
- Medical Diagnostics and Treatments 12.52M 79.7%
- Radiation Therapy and Medical Oncology Services 3.19M 20.3%
Fiscal year ended Jun 30, 2026 See the full SGXC:9G2 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 15.72M | 8.38K | 0.05% |
| Jun 30, 2025 | 15.71M | -936.78K | -5.63% |
| Jun 30, 2024 | 16.65M | 412.41K | 2.54% |
| Jun 30, 2023 | 16.23M | 2.43M | 17.56% |
| Jun 30, 2022 | 13.81M | 891.35K | 6.90% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vallianz Holdings | 252.46M |
| UG Healthcare Corporation | 150.82M |
| Lincotrade & Associates Holdings | 129.50M |
| ISOTeam | 105.75M |
| Kim Heng | 97.73M |
| Wong Fong Industries | 79.06M |
| Octopus (APAC) Holdings | 74.78M |
| Toku Ltd. | 47.78M |